The programme is focussing on the following: translational research (i.e. the translation of the results of the basic research into clinical applications), the development and validation of new therapies, methods for health promotion and prevention including promotion of child health, healthy ageing, diagnostic tools and medical technologies, as well as sustainable and efficient health care systems.

I. Biotechnology, generic tools and medical technologies for human health

• High-throughput research
• Detection, Diagnosis and monitoring
• Suitability, safety, efficacy of therapies
• Innovative therapeutic approaches and interventions

II. Translating research for human health

• Integrating biological data and process: large scale data gathering system biology
• Research on the brain and brain-related diseases, human development and ageing
• Translational research in major infectious diseases: to confront major threats to public health
• Translational research in other major diseases

III. Optimising the delivery of healthcare to European citizens

• Translating the results of clinical research outcome into clinical practise including better use of medicines and appropriate use of behavioural and organisational interventions and new health therapies and technologies
• Quality, efficiency and solidarity of healthcare systems including transitional health systems
• Enhanced health promotion and disease prevention

The cross-cutting and strategic themes "child health" and "health of the aging population" will be taken into account by all activities. Healthy ageing is also the topic of the first so-called innovation partnership (the 'European Innovation Partnership on active and healthy ageing ").